| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 48% | 12/25 |
| Female | 52% | 13/25 |
| Indifferent | 0% | 0/25 |
| Unknown | 0% | 0/25 |
| General | ||
| 16% | 4/25 | |
| 12% | 3/25 | |
| 16% | 4/25 | |
| 44% | 11/25 | |
| 32% | 8/25 | |
| 32% | 8/25 | |
| 44% | 11/25 | |
| 56% | 14/25 | |
| 52% | 13/25 | |
| 30% | 3/10 | |
| Neurology | ||
| 36% | 9/25 | |
| 28% | 7/25 | |
| 40% | 10/25 | |
| Facial abnormalities | ||
| 32% | 8/25 | |
| 80% | 20/25 | |
| 56% | 14/25 | |
| 80% | 20/25 | |
| Visual and hearing impairments | ||
| 20% | 5/25 | |
| 44% | 11/25 | |
| Heart | ||
| 44% | 11/25 | |
| Pulmonary | ||
| 4% | 1/25 | |
| Gastrointestinal | ||
| 40% | 10/25 | |
| Urogenital | ||
| 48% | 12/25 | |
| Skeleton | ||
| 96% | 24/25 | |
| Skin / Hair / Nails | ||
| 48% | 12/25 | |
| Endocrine / Immunological / Metabolic | ||
| 4% | 1/25 | |
| 4% | 1/25 | |
| 4% | 1/25 | |
| Neoplasia | ||
| 4% | 1/25 | |
| Inheritance | ||
| 84% | 21/25 | |
PUF60